Cargando…

Can visuospatial measures improve the diagnosis of Alzheimer's disease?

INTRODUCTION: Overlapping and evolving symptoms lead to ambiguity in the diagnosis of dementia. Visuospatial function relies on parietal lobe function, which may be affected in the early stages of Alzheimer's disease (AD). This review evaluates visuospatial dysfunction in patients with AD, fron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salimi, Shirin, Irish, Muireann, Foxe, David, Hodges, John R., Piguet, Olivier, Burrell, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Cognitive & Behavioral Assessment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956809/ https://www.ncbi.nlm.nih.gov/pubmed/29780858 http://dx.doi.org/10.1016/j.dadm.2017.10.004

Ejemplares similares

Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers
por: Wise, Elizabeth A., et al.
Publicado: (2019)

The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
por: Hartry, Ann, et al.
Publicado: (2018)

A novel cognitive-functional composite measure to detect changes in early Alzheimer's disease: Test–retest reliability and feasibility
por: Jutten, Roos J., et al.
Publicado: (2017)

Improving the quality of cognitive screening assessments: ACEmobile, an iPad-based version of the Addenbrooke's Cognitive Examination-III
por: Newman, Craig G.J., et al.
Publicado: (2017)

Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?
por: Tarnanas, Ioannis, et al.
Publicado: (2015)

Uniform data set language measures for bvFTD and PPA diagnosis and monitoring
por: Staffaroni, Adam M., et al.
Publicado: (2021)

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease
por: Motter, Jeffrey N., et al.
Publicado: (2021)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

δ scores predict mild cognitive impairment and Alzheimer's disease conversions from nondemented states
por: Royall, Donald R., et al.
Publicado: (2017)

Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease
por: Papp, Kathryn V., et al.
Publicado: (2021)

Cardiorespiratory fitness mitigates brain atrophy and cognitive decline in adults at risk for Alzheimer's disease
por: Dougherty, Ryan J., et al.
Publicado: (2021)

Automated text‐level semantic markers of Alzheimer's disease
por: Sanz, Camila, et al.
Publicado: (2022)

Cardiorespiratory fitness and cognition in persons at risk for Alzheimer's disease
por: Vesperman, Clayton J., et al.
Publicado: (2022)

Automatic speech analysis for the assessment of patients with predementia and Alzheimer's disease
por: König, Alexandra, et al.
Publicado: (2015)

Utility of the NIH Toolbox for assessment of prodromal Alzheimer's disease and dementia
por: Hackett, Katherine, et al.
Publicado: (2018)

Analyzing large Alzheimer's disease cognitive datasets: Considerations and challenges
por: Bellio, Maura, et al.
Publicado: (2020)

A quadratic function of activation in individuals at risk of Alzheimer's disease
por: Corriveau‐Lecavalier, Nick, et al.
Publicado: (2021)

Current advances in digital cognitive assessment for preclinical Alzheimer's disease
por: Öhman, Fredrik, et al.
Publicado: (2021)

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2021)

A cognitive stress test for prodromal Alzheimer's disease: Multiethnic generalizability
por: Curiel Cid, Rosie E., et al.
Publicado: (2019)

Scientific and ethical features of English-language online tests for Alzheimer's disease
por: Robillard, Julie M., et al.
Publicado: (2015)

Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease
por: Samaroo, Aubryn, et al.
Publicado: (2021)

A profile of brain reserve in adults at genetic risk of Alzheimer's disease
por: Coughlan, Gillian, et al.
Publicado: (2021)

Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease
por: Grossman, Hillel T., et al.
Publicado: (2022)

Causal association of cognitive reserve on Alzheimer's disease with putative sex difference
por: Wang, Hao, et al.
Publicado: (2021)

Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID‐19
por: Geddes, Maiya R., et al.
Publicado: (2020)

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score
por: Lim, Yen Ying, et al.
Publicado: (2015)

BHA‐CS: A novel cognitive composite for Alzheimer's disease and related disorders
por: Tsoy, Elena, et al.
Publicado: (2020)

Fractal motor activity regulation and sex differences in preclinical Alzheimer's disease pathology
por: Gao, Lei, et al.
Publicado: (2021)

Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort
por: Sánchez-Benavides, Gonzalo, et al.
Publicado: (2016)

Quantification of cognitive impairment to characterize heterogeneity of patients at risk of developing Alzheimer's disease dementia
por: Giraldo, Diana L., et al.
Publicado: (2021)

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
por: Anderson, Eric D., et al.
Publicado: (2016)

Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease
por: Schoemaker, Dorothee, et al.
Publicado: (2015)

Semantic loss marks early Alzheimer's disease‐related neurodegeneration in older adults without dementia
por: Vonk, Jet M. J., et al.
Publicado: (2020)

Validation of the National Alzheimer's Coordinating Center (NACC) Lewy Body Disease Module neuropsychological tests
por: Rahman‐Filipiak, Annalise, et al.
Publicado: (2022)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021)

Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials
por: Goldberg, Terry E., et al.
Publicado: (2015)

Analysis of macrolinguistic aspects of narratives from individuals with Alzheimer's disease, mild cognitive impairment, and no cognitive impairment
por: Toledo, Cíntia Matsuda, et al.
Publicado: (2017)

Understanding hallucinations in probable Alzheimer's disease: Very low prevalence rates in a tertiary memory clinic
por: Linszen, Mascha M.J., et al.
Publicado: (2018)

Apraxia profiles—A single cognitive marker to discriminate all variants of frontotemporal lobar degeneration and Alzheimer's disease
por: Johnen, Andreas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tp5n3b2iufhp10nk7m9p8dred6